DE NICOLA, STELLA
 Distribuzione geografica
Continente #
EU - Europa 1.688
NA - Nord America 1.192
AS - Asia 960
SA - Sud America 92
AF - Africa 29
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 3.977
Nazione #
US - Stati Uniti d'America 1.149
GB - Regno Unito 747
DE - Germania 391
CN - Cina 292
SG - Singapore 278
IT - Italia 132
SE - Svezia 131
RU - Federazione Russa 93
HK - Hong Kong 87
VN - Vietnam 82
BR - Brasile 73
BD - Bangladesh 59
IN - India 58
FR - Francia 38
CA - Canada 35
NL - Olanda 35
TR - Turchia 35
IE - Irlanda 29
FI - Finlandia 25
UA - Ucraina 22
KR - Corea 20
EU - Europa 19
DK - Danimarca 13
BE - Belgio 12
EG - Egitto 12
ID - Indonesia 12
AU - Australia 8
JP - Giappone 7
ZA - Sudafrica 7
CO - Colombia 5
IQ - Iraq 5
PH - Filippine 5
MA - Marocco 4
MX - Messico 4
RO - Romania 4
UZ - Uzbekistan 4
AR - Argentina 3
CI - Costa d'Avorio 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
ES - Italia 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
LV - Lettonia 2
MY - Malesia 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.992
Città #
Southend 716
Singapore 159
Ashburn 128
Chandler 120
Hanover 109
Hong Kong 76
San Jose 76
Beijing 64
Seattle 62
Frankfurt am Main 61
Ann Arbor 56
Milan 46
Wilmington 43
Princeton 41
Dearborn 36
New York 33
Fairfield 32
Woodbridge 30
Dallas 29
Dublin 29
Hanoi 29
Ho Chi Minh City 29
Los Angeles 28
Council Bluffs 27
Toronto 25
Houston 22
Andover 18
Redmond 18
Cambridge 17
Lauterbourg 17
Margão 17
Santa Clara 17
Buffalo 15
Des Moines 15
Munich 15
Moscow 14
Nanjing 14
Phoenix 14
Columbus 13
Shanghai 13
Brussels 12
Guangzhou 12
Mountain View 12
Saint Petersburg 11
Somerville 11
Boardman 10
Sakarya 10
The Dalles 10
Berlin 9
Jinan 9
Mumbai 9
Grafing 8
Shenyang 8
Ottawa 7
Tianjin 7
Atlanta 6
Bengaluru 6
Helsinki 6
London 6
Stockholm 6
Tokyo 6
Bogotá 5
Da Nang 5
Jakarta 5
Jiaxing 5
Johannesburg 5
Kent 5
Nuremberg 5
Pisa 5
Rome 5
San Diego 5
Silver Spring 5
Cangzhou 4
Chicago 4
Eitensheim 4
Hamburg 4
Hangzhou 4
Nanchang 4
Odernheim 4
Orem 4
Abidjan 3
Baghdad 3
Brasília 3
Brisbane 3
Dhaka 3
Falls Church 3
Fuzhou 3
Haiphong 3
Hefei 3
Istanbul 3
Naples 3
New Delhi 3
Portici 3
Rabat 3
Redwood City 3
San Francisco 3
São Paulo 3
Taizhou 3
Turku 3
Vadodara 3
Totale 2.651
Nome #
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients 390
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent 344
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C 304
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C 242
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy 231
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 223
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 219
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 209
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection 206
Effect of the PNPLA3 I148M polymorphism on the outcome of peg-interferon plus ribavirin treatment in chronic hepatitis C 202
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 200
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 200
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 199
PNPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 192
Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis 192
Twelve-week post-treatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy 175
Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis 161
HCV-RNA kinetics on-treatment do not predict sustained virologic response in HCV genotype 3 patients receiving sofosbuvir and ribavirin 156
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 91
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database 9
Hepatitis C eradication improves oncologic and clinical outcomes in patients treated with Atezolizumab plus Bevacizumab 8
Totale 4.153
Categoria #
all - tutte 10.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 63 29
2021/2022411 19 25 8 27 66 58 47 21 37 26 30 47
2022/2023346 44 57 33 39 32 72 0 17 38 0 11 3
2023/2024179 6 14 11 11 29 10 14 12 7 13 21 31
2024/2025473 17 61 16 65 36 13 10 33 18 50 48 106
2025/20261.040 130 48 98 68 95 62 183 46 93 64 153 0
Totale 4.153